Hsien-Chao Chou

13PUBLICATIONS
113CO-AUTHORS
Molecular targetsHaematological tumoursPredictive and prognostic markersSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 08, 2025
RUNX2 inhibition disrupts a PAX3::FOXO1-RUNX2 feed-forward loop and dismantles oncogenic gene programs in fusion-positive rhabdomyosarcoma.

Elizabeth A Mendes, Aanandi Munshi, Archana Singh

|Jul 23, 2024
CAR T-cells targeting FGFR4 and CD276 simultaneously show potent antitumor effect against childhood rhabdomyosarcoma.

Meijie Tian, Jun S Wei, Adam Tai-Chi Cheuk

|Apr 23, 2024
Lineage specific transcription factor waves reprogram neuroblastoma from self-renewal to differentiation.

Deblina Banerjee, Sukriti Bagchi, Zhihui Liu

|Feb 24, 2024
KDM3B inhibitors disrupt the oncogenic activity of PAX3-FOXO1 in fusion-positive rhabdomyosarcoma.

Yong Yean Kim, Berkley E Gryder, Ranuka Sinniah

|Sep 21, 2023
Piperacetazine Directly Binds to the PAX3::FOXO1 Fusion Protein and Inhibits Its Transcriptional Activity.

Kay Nakazawa, Taryn Shaw, Young K Song

Pageof 3